Boston Scientific (BSX) Cash & Current Investments (2009 - 2026)

Boston Scientific's Cash & Current Investments history runs 18 years deep, the most recent figure standing at $1.5 billion for Q1 2026.

• In Q1 2026, Cash & Current Investments rose 100.41% year-over-year to $1.5 billion; the TTM figure through Mar 2026 stood at $1.5 billion (up 100.41% YoY), while the FY2025 annual figure was $2.0 billion, up 224.26% from the prior year.
• Cash & Current Investments came in at $1.5 billion for Q1 2026 at Boston Scientific, down from $2.0 billion in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $2.9 billion in Q2 2024 to a low of $276.0 million in Q2 2022.
• A 5-year average of $1.1 billion and a median of $865.0 million in 2023 frame the typical range for Cash & Current Investments.
• Across the five-year window, Cash & Current Investments slumped 89.68% in 2022 and surged 583.8% in 2024, its largest moves.
• Boston Scientific's Cash & Current Investments stood at $928.0 million in 2022, then slipped by 6.79% to $865.0 million in 2023, then slipped by 29.94% to $606.0 million in 2024, then soared by 224.26% to $2.0 billion in 2025, then decreased by 26.06% to $1.5 billion in 2026.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $1.5 billion, $2.0 billion, and $1.3 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison